Overview
- 10 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-12-19.
At a glance
Inspections
10
Form 483s
5
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 15 Dec 2025 – 19 Dec 2025 | Human Drugs | Clean | |
| 31 Jul 2025 – 1 Aug 2025 | Human Drugs | Clean | |
| 21 Dec 2023 – 22 Dec 2023 | Human Drugs | Clean | |
| 23 Sep 2019 – 26 Sep 2019 | Human Drugs | Clean | |
| 18 May 2015 – 21 May 2015 | Medical Devices & Rad Health | 483 | On file |
| 12 Feb 2014 – 13 Feb 2014 | Human Drugs | Clean | |
| 8 Jan 2014 – 22 Jan 2014 | Human Drugs | 483 | View 483 → |
| 8 Nov 2012 | Not recorded | 483 | View 483 → |
| 12 Dec 2011 | Not recorded | 483 | On file |
| 20 Aug 2010 | Not recorded | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
8 Nov 2012
21 CFR 211.188
Prepared for each batch, include complete information
Cited by Mark E Chan, Caryn M Mcnab
8 Nov 2012
21 CFR 211.188(b)(7)
Actual yield, % of theoretical yield
Cited by Mark E Chan, Caryn M Mcnab
20 Aug 2010
21 CFR 211.22(a)
Authority lacking to review records, investigate errors
Cited by Mark E Chan, Peter E Baker
Investigators
FDA investigators tied to this site in the record.
Mark E Chan3 insp.
Ashar P Parikh2 insp.
Seneca D Toms1 insp.
Carolina D Vasquez1 insp.
Tiara M Brown1 insp.
Joey V Quitania1 insp.
Gunneet Kaur1 insp.
Anney Lin1 insp.
Kristin M Abaonza1 insp.
Jolanna A Norton1 insp.
Daniel J Roberts1 insp.
David Eng1 insp.
Caryn M Mcnab1 insp.
Lance M De Souza1 insp.
William V Millar1 insp.
Peter E Baker1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.142 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(7) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.75(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Nova Pneuma, Inc.'s 5 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat